Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Unbalanced translocations of 20q in AML and MDS often involve interstitial rather than terminal deletions of 20q.

MacKinnon RN, Duivenvoorden HM, Campbell LJ.

Cancer Genet. 2011 Mar;204(3):153-61. doi: 10.1016/j.cancergen.2010.12.001.

PMID:
21504715
2.

A new nonrandom unbalanced t(17;20) in myeloid malignancies.

Patsouris C, Michael PM, Campbell LJ.

Cancer Genet Cytogenet. 2002 Oct 1;138(1):32-7.

PMID:
12419582
4.

Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20.

Mackinnon RN, Campbell LJ.

Cytogenet Genome Res. 2007;119(3-4):211-20. doi: 10.1159/000112063.

PMID:
18253031
5.

Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.

Volkert S, Kohlmann A, Schnittger S, Kern W, Haferlach T, Haferlach C.

Genes Chromosomes Cancer. 2014 May;53(5):402-10. doi: 10.1002/gcc.22151.

PMID:
24493299
6.

A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG)

Jaju RJ, Haas OA, Neat M, Harbott J, Saha V, Boultwood J, Brown JM, Pirc-Danoewinata H, Krings BW, Müller U, Morris SW, Wainscoat JS, Kearney L.

Blood. 1999 Jul 15;94(2):773-80.

7.

Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH).

Tosi S, Harbott J, Haas OA, Douglas A, Hughes DM, Ross FM, Biondi A, Scherer SW, Kearney L.

Leukemia. 1996 Apr;10(4):644-9.

PMID:
8618441
8.

Consistent interstitial chromosomal deletions in myeloid malignancies and their correlation with fragile sites.

Hirst WJ, Czepulkowski B, Mufti GJ.

Cancer Genet Cytogenet. 1993 Jan;65(1):51-7.

PMID:
8431916
9.

Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.

Trost D, Hildebrandt B, Beier M, Müller N, Germing U, Royer-Pokora B.

Cancer Genet Cytogenet. 2006 Feb;165(1):51-63.

PMID:
16490597
10.

Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.

Fischer K, Fröhling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui LC, Lichter P, Döhner H.

Blood. 1997 Mar 15;89(6):2036-41.

11.

Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.

Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP.

Genes Chromosomes Cancer. 2010 Apr;49(4):390-9. doi: 10.1002/gcc.20748.

PMID:
20095039
12.

Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.

Bram S, Swolin B, Rödjer S, Stockelberg D, Ogärd I, Bäck H.

Cancer Genet Cytogenet. 2003 Apr 15;142(2):107-14.

PMID:
12699885
13.

[Rearrangements of chromosome 9 in different hematological neoplasia].

Andreeva SV, Drozdova VD, Ponochevnaia EV, Kavardakova NV.

Tsitol Genet. 2008 Sep-Oct;42(5):72-9. Russian.

PMID:
19140443
14.

[Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].

Zhu Y, Xu W, Liu Q, Pan J, Qiu H, Wang R, Qiao C, Jiang Y, Zhang S, Fan L, Zhang J, Shen Y, Xue Y, Li J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Oct;25(5):579-82. Chinese.

PMID:
18841577
15.

The paradox of 20q11.21 amplification in a subset of cases of myeloid malignancy with chromosome 20 deletion.

Mackinnon RN, Selan C, Wall M, Baker E, Nandurkar H, Campbell LJ.

Genes Chromosomes Cancer. 2010 Nov;49(11):998-1013. doi: 10.1002/gcc.20806.

PMID:
20645416
16.

dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.

Wang P, Spielberger RT, Thangavelu M, Zhao N, Davis EM, Iannantuoni K, Larson RA, Le Beau MM.

Genes Chromosomes Cancer. 1997 Nov;20(3):282-91.

PMID:
9365836
17.
18.

17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.

Soenen V, Preudhomme C, Roumier C, Daudignon A, Laï JL, Fenaux P.

Blood. 1998 Feb 1;91(3):1008-15.

19.

Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.

Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA.

Blood. 1992 Mar 15;79(6):1501-10.

20.

Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms.

Castro PD, Liang JC, Nagarajan L.

Blood. 2000 Mar 15;95(6):2138-43.

Items per page

Supplemental Content

Support Center